Shanghai Kaibao Pharmaceutical (300039) — Capital Reinvestment Ratio
Shanghai Kaibao Pharmaceutical (300039) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥190.98 Million) in capital expenditures (CN¥3.37 Million). Check 300039 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Kaibao Pharmaceutical Capital Reinvestment Ratio (2006–2025)
This chart tracks Shanghai Kaibao Pharmaceutical's Capital Reinvestment Ratio across 20 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shanghai Kaibao Pharmaceutical.
Annual Capital Reinvestment Ratio for Shanghai Kaibao Pharmaceutical (2006–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Kaibao Pharmaceutical from 2006 to 2025. See cash generation quality of Shanghai Kaibao Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | CN¥230.74 Million | CN¥27.04 Million | ▼ -76.7% |
| 2024 | 0.50x | CN¥278.95 Million | CN¥140.52 Million | ▲ +563.0% |
| 2023 | 0.08x | CN¥382.66 Million | CN¥29.08 Million | ▼ -9.5% |
| 2022 | 0.08x | CN¥376.42 Million | CN¥31.62 Million | ▼ -75.1% |
| 2021 | 0.34x | CN¥126.08 Million | CN¥42.55 Million | ▲ +506.8% |
| 2020 | 0.06x | CN¥250.65 Million | CN¥13.94 Million | ▲ +20.2% |
| 2019 | 0.05x | CN¥334.09 Million | CN¥15.46 Million | ▼ -53.4% |
| 2018 | 0.10x | CN¥262.36 Million | CN¥26.07 Million | ▼ -50.4% |
| 2017 | 0.20x | CN¥245.76 Million | CN¥49.24 Million | ▲ +133.4% |
| 2016 | 0.09x | CN¥314.88 Million | CN¥27.03 Million | ▼ -44.3% |
| 2015 | 0.15x | CN¥327.08 Million | CN¥50.40 Million | ▼ -36.7% |
| 2014 | 0.24x | CN¥282.38 Million | CN¥68.74 Million | ▼ -44.4% |
| 2013 | 0.44x | CN¥270.23 Million | CN¥118.28 Million | ▲ +104.0% |
| 2012 | 0.21x | CN¥243.32 Million | CN¥52.21 Million | ▼ -69.4% |
| 2011 | 0.70x | CN¥98.31 Million | CN¥68.85 Million | ▼ -72.8% |
| 2010 | 2.58x | CN¥19.79 Million | CN¥51.01 Million | ▲ +8.1% |
| 2009 | 2.38x | CN¥52.74 Million | CN¥125.70 Million | ▲ +294.9% |
| 2008 | 0.60x | CN¥18.70 Million | CN¥11.28 Million | ▲ +204.1% |
| 2007 | 0.20x | CN¥23.27 Million | CN¥4.62 Million | ▼ -66.7% |
| 2006 | 0.60x | CN¥19.70 Million | CN¥11.74 Million | — |